|
Optometry and Vision Science
Online Submission and Review System
|
|
Optometry and Vision Science is the peer-reviewed journal of the American Academy of Optometry. It is an authoritative source for current developments in optometry, physiological optics, vision and eye science.
Optometry and Vision Science (OVS) is published monthly and considers manuscripts on all aspects of the eye and vision including, but not limited to: clinical, experimental, and theoretical studies in optometry and related fields, case reports, clinical techniques, public health, epidemiology, optics and instrumentation, biology of eye and eye disease, and optometric education.
ETHICAL/LEGAL CONSIDERATIONS
A submitted manuscript must be an original contribution not previously published (except as an abstract or a preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of the OVS Editor-in-Chief (on behalf of the American Academy of Optometry). Each person listed as an author is expected to have participated in the study to a significant extent. During the manuscript submission process, the corresponding author will be required to state that all authors accept public responsibility for the manuscript. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher. All manuscripts must be submitted on-line through the journal’s Web site at https://ovs.edmgr.com/. See submission instructions on the next page, under “On-line manuscript submission”.
Human Subjects and Informed Consent/Animal Subjects: If human subjects were involved in the study, the authors must confirm that the research followed the tenets of the Declaration of Helsinki, that informed consent was obtained from the subjects after explanation of the nature and possible consequences of the study, and, where applicable, the research was approved by the appropriate institutional review board (IRB). A statement confirming this must appear in the Methods section of the manuscript.
It is the author’s responsibility to ensure that a patient’s anonymity be carefully protected and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask identifying features and remove patients’ names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.
All authors of research involving animals are expected to follow the ARVO guidelines, outlined in detail at: http://www.arvo.org/eweb/dynamicpage.aspx?site_arvo2&webcode_AnimalsResearch#Recommended%20References.
Copyright: All authors must sign a copy of the Journal’s “Copyright Transfer” form and upload a PDF of the signed statement at the time of manuscript submission. If unable to upload a PDF, submit the signed statement via fax to 614-292-4949 at the time of submission and then forward the original to the Editorial Office (email ovs@osu.edu for the mailing address).
Compliance with NIH and Other Research Funding Agency Accessibility Requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
Disclosure statement: Each author must warrant that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might be perceived as a conflict of interest in connection with the submitted manuscript. If a commercial interest or potential conflict of interest exists, it MUST be disclosed for each author in the “Author’s Comments” box during the submission process and included in the “ACKNOWLEDGMENTS” of the manuscript. All funding sources supporting the Work and all institutional or corporate affiliations of the authors are also to be listed in the “ACKNOWLEDGMENTS”.
Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form else where, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, not the responsibility of Lippincott Williams & Wilkins or the American Academy of Optometry.
MANUSCRIPT SUBMISSION
On-line manuscript submission: All manuscripts must be submitted on-line through the Web site at https://ovs.edmgr.com/. OVS does not accept Word 2007 “.docx” files.
First-time users: Please click the “Register” button at https://ovs.edmgr.com/ and enter the requested information. On successful registration, you will be sent an e-mail indicating your username and password. Note: If you have received an e-mail from us with an assigned username and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned username and password, you do not have to re-register, even if your status changes (that is, author, reviewer, or editor).
Authors: Click the log-in button from the menu at the top of the page and log in to the system as an “Author”. Click on “Submit New Manuscript” then follow the submission steps provided.
If you experience any problems, contact Kurt Zadnik, ovs@osu.edu, 614-292-4942.
PREPARATION OF MANUSCRIPT
Authors should closely follow the instructions for submission of manuscripts. The Journal follows most of the recommendations of the International Committee of Medical Journal Editors’ Uniform Requirements for Manuscripts Submitted to Biomedical Journals (www.icmje.org).
Compliance with NIH and Other Research Funding Agency Accessibility Requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
The submission should be submitted double-spaced with text lines numbered consecutively.
Make all measurements and units metric with the possible exception of visual acuity. Lens prescriptions or refractive errors should be expressed as: RE (or OD) _2.25 - 1.00 X 95.
The order for the complete submission is as follows:
Title page: Title page must be submitted as a separate file.
Include on the title page:
Structured abstract & key words: Submit the abstract as a separate file. Limit the abstract to 300 words or less. For Original Articles a four-part structured abstract is required. Separate into Purpose, Methods, Results, and Conclusions. Do not cite references. Define all abbreviations. List at least 5 key words.
Text: The body of the manuscript should begin with an untitled introduction which provides background and rationale for the study; it is important to include the main potential clinical implications of the work, even if it is not a clinical study. Methods, Results, and Discussion follow.
Other text formats may be appropriate, for example Case Reports, in addition to an Abstract, have an untitled introduction, Case Report, and Discussion.
Acknowledgments: All sources of support in the form of grants or other significant assistance should be acknowledged concisely. Any potential conflicts of interest that may appear to exist should be disclosed, particularly the presence or absence of any financial interest in any of the products mentioned in the manuscript. If the manuscript has been presented in public as a paper or poster, include the name, date, and place of that meeting.
References: Number references consecutively in the order of their citation in the text and identify by superscript numbers. Do not insert references as footnotes. Authors are responsible for making sure that each reference is correctly cited and listed. It is strongly recommended that authors use a reference management system such as Endnote. References must be in the form currently used in the Journal. A style file containing the journal’s format for references is available on the Journal home page (https://ovs.edmgr.com/)
Sample references are given below:
Journal article
Thibos LN, Wheeler W, Horner D. Power vectors: an application of Fourier analysis to the description and statistical analysis of refractive error. Optom Vis Sci 1997;74:367–75.
Book chapter
Todd VR. Visual information analysis: frame of reference for visual perception. In: Kramer P, Hinojosa J, eds. Frames of Reference for Pediatric Occupational Therapy. Philadelphia: Lippincott Williams & Wilkins; 1999:205–56.
Entire book
Kellman RM, Marentette LJ. Atlas of Craniomaxillofacial Fixation. Philadelphia: Lippincott Williams & Wilkins; 1999.
AAO meeting abstract
Before 2005:
Omlor RA, Mutti DO. Differences in axial length using A-scan ultrasonography and IOL Master: effects of anterior chamber depth. Optom Vis Sci 2003;80(suppl.):120.
Beginning 2005:
Blacker AB, Mitchell GL, Bullimore MA, Long B, Dillehay SM, Barr JT, Bergenske PD, Donshik P, Secor GB, Yoakum J. Myopia progression in contact lens wearers. Optom Vis Sci 2006;83:E-abstract 060025.
Software
Epi Info [computer program]. Version 6. Atlanta, GA: Centers for Disease Control and Prevention; 1994.
Online journals
Bex PJ, Langley K. The perception of suprathreshold contrast and fast adaptive filtering. J Vis 2007;7(12):1–23. Available at: http://journalofvision.org/7/12/1/. Accessed October 10, 2007.
Online sources
Global Initiative for the Elimination of Avoidable Blindness.WHO/PBL/97.61. Geneva: World Health Organization, 1997:1–7. Available at: http://whqlibdoc.who.int/hq/1997/WHO_PBL_97.61.pdf. Accessed July 7, 2006.
Database
CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996.
Tables: Do not embed tables within the body of the manuscript. Create tables using the table creating and editing feature of your word processing software (eg, Word). Do not use Excel or comparable spreadsheet programs. Group all tables in a separate file and upload them as a separate file, after the manuscript. Cite tables consecutively in the text, and number them with Arabic numerals in that order. Each table should appear on a separate sheet and should include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). They should be self-explanatory and should supplement, rather than duplicate, the material in the text. Data that can be described in two or three sentences should be presented in the text and not in a table.
Figure legends: Submit all figures legends on a separate manuscript page after the references. Be brief and specific. Use scale markers in the image for electron micrographs, and indicate the type of stain used. No legends should appear on the figures and titles should be avoided.
Figures: Do not embed Figures within the text of the manuscript. Art should be created/scanned and saved and submitted as either a TIFF (tagged image file format) or a PPT (PowerPoint) file. Line art and electronic photographs—radiographs, CT scans, and scanned images must have a resolution of at least 600 ppi at 3.5_ width.
If fonts are used in the artwork, they must be converted to paths or outlines or embedded in the files.
The Journal prefers “Arial” or “Helvetica” font. All key boxes must be included within the body of the figure, not in the margin. Artwork generated from office suite programs such CorelDRAW and MS Word and artwork downloaded from the Internet (JPEG or GIF files) cannot be used.
Guidelines for producing publication-quality artwork is available via the OVS/Editorial Manager homepage by clicking “5 Steps to Creating Digital Artwork (PDF)”.
Upload figures consecutively, and number them in the order in which they are discussed in the text. All electronic art that cannot be successfully uploaded must be submitted via overnight courier to the Editorial Office on a CD-ROM, accompanied by high-resolution laser prints of each image.
Color figures: The journal accepts for publication color figures that will enhance an article. Color images must be created/scanned and saved and submitted as CMYK files. Authors who submit color figures are expected to pay the cost for the print publication. If they decide not to pay for color reproduction, the figures will be converted to black and white at no charge. The color versions of their figures will appear, at no charge, in the online version of the journal at www.opvissci.com.
Style: Pattern manuscript style after the American Medical Association Manual of Style (9th edition). Stedman’s Medical Dictionary (27th edition) and Merriam Webster’s Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. The name should not be abbreviated. Use code numbers only when a generic name is not yet available. Copyright or trade names of drugs should be capitalized and placed in parentheses after the name of the drug. Names and locations (city and state in USA; city and country outside USA) of manufacturers of drugs, supplies, or equipment cited in a manuscript are required to comply with trademark law and should be provided in parentheses. Units of measure should be expressed in the metric system (with the possible exception of visual acuity), and temperatures should be expressed in degrees Celsius. Conventional units should be written as SI units as appropriate.
AFTER ACCEPTANCE
Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Proofs must be checked carefully and corrections emailed, faxed and/or electronically returned to the publisher within 48 hours of receipt.
It is the author’s responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors’ meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries.
PDF files of the typeset pages and support documents (eg, reprint order form) will be made available on a secure website. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing or electronic submission of the corrected page proofs to the publisher.
Reprints: Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be emailed or faxed to the publisher with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106 with any questions.
Publisher’s contact: Email or fax corrected page proofs, reprint order form, and any other related materials to Journal Production Editor, Optometry and Vision Science, 215-521-8483 or 215-521-8485.
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
The submission should be submitted double-spaced with text lines numbered consecutively.
Make all measurements and units metric with the possible exception of visual acuity. Lens prescriptions or refractive errors should be expressed as: RE (or OD) _2.25 - 1.00 X 95.
The order for the complete submission is as follows:
Title page: Title page must be submitted as a separate file.
Include on the title page:
(a) manuscript title, limited to 70 characters or less;Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
(b) authors’ full names, highest academic degrees (no more than two) plus, if appropriate, FAAO, and institutional affiliations;
(c) the number of tables and figures;
(d) name and full mailing address for correspondence, fax number and e-mail address;
(e) address for reprints if different from that of corresponding author;
(f) the date the paper was submitted.
Structured abstract & key words: Submit the abstract as a separate file. Limit the abstract to 300 words or less. For Original Articles a four-part structured abstract is required. Separate into Purpose, Methods, Results, and Conclusions. Do not cite references. Define all abbreviations. List at least 5 key words.
Text: The body of the manuscript should begin with an untitled introduction which provides background and rationale for the study; it is important to include the main potential clinical implications of the work, even if it is not a clinical study. Methods, Results, and Discussion follow.
Other text formats may be appropriate, for example Case Reports, in addition to an Abstract, have an untitled introduction, Case Report, and Discussion.
Acknowledgments: All sources of support in the form of grants or other significant assistance should be acknowledged concisely. Any potential conflicts of interest that may appear to exist should be disclosed, particularly the presence or absence of any financial interest in any of the products mentioned in the manuscript. If the manuscript has been presented in public as a paper or poster, include the name, date, and place of that meeting.
References: Number references consecutively in the order of their citation in the text and identify by superscript numbers. Do not insert references as footnotes. Authors are responsible for making sure that each reference is correctly cited and listed. It is strongly recommended that authors use a reference management system such as Endnote. References must be in the form currently used in the Journal. A style file containing the journal’s format for references is available on the Journal home page (https://ovs.edmgr.com/)
Sample references are given below:
Journal article
Thibos LN, Wheeler W, Horner D. Power vectors: an application of Fourier analysis to the description and statistical analysis of refractive error. Optom Vis Sci 1997;74:367–75.
Book chapter
Todd VR. Visual information analysis: frame of reference for visual perception. In: Kramer P, Hinojosa J, eds. Frames of Reference for Pediatric Occupational Therapy. Philadelphia: Lippincott Williams & Wilkins; 1999:205–56.
Entire book
Kellman RM, Marentette LJ. Atlas of Craniomaxillofacial Fixation. Philadelphia: Lippincott Williams & Wilkins; 1999.
AAO meeting abstract
Before 2005:
Omlor RA, Mutti DO. Differences in axial length using A-scan ultrasonography and IOL Master: effects of anterior chamber depth. Optom Vis Sci 2003;80(suppl.):120.
Beginning 2005:
Blacker AB, Mitchell GL, Bullimore MA, Long B, Dillehay SM, Barr JT, Bergenske PD, Donshik P, Secor GB, Yoakum J. Myopia progression in contact lens wearers. Optom Vis Sci 2006;83:E-abstract 060025.
Software
Epi Info [computer program]. Version 6. Atlanta, GA: Centers for Disease Control and Prevention; 1994.
Online journals
Bex PJ, Langley K. The perception of suprathreshold contrast and fast adaptive filtering. J Vis 2007;7(12):1–23. Available at: http://journalofvision.org/7/12/1/. Accessed October 10, 2007.
Online sources
Global Initiative for the Elimination of Avoidable Blindness.WHO/PBL/97.61. Geneva: World Health Organization, 1997:1–7. Available at: http://whqlibdoc.who.int/hq/1997/WHO_PBL_97.61.pdf. Accessed July 7, 2006.
Database
CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996.
Tables: Do not embed tables within the body of the manuscript. Create tables using the table creating and editing feature of your word processing software (eg, Word). Do not use Excel or comparable spreadsheet programs. Group all tables in a separate file and upload them as a separate file, after the manuscript. Cite tables consecutively in the text, and number them with Arabic numerals in that order. Each table should appear on a separate sheet and should include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). They should be self-explanatory and should supplement, rather than duplicate, the material in the text. Data that can be described in two or three sentences should be presented in the text and not in a table.
Figure legends: Submit all figures legends on a separate manuscript page after the references. Be brief and specific. Use scale markers in the image for electron micrographs, and indicate the type of stain used. No legends should appear on the figures and titles should be avoided.
Figures: Do not embed Figures within the text of the manuscript. Art should be created/scanned and saved and submitted as either a TIFF (tagged image file format) or a PPT (PowerPoint) file. Line art and electronic photographs—radiographs, CT scans, and scanned images must have a resolution of at least 600 ppi at 3.5_ width.
If fonts are used in the artwork, they must be converted to paths or outlines or embedded in the files.
The Journal prefers “Arial” or “Helvetica” font. All key boxes must be included within the body of the figure, not in the margin. Artwork generated from office suite programs such CorelDRAW and MS Word and artwork downloaded from the Internet (JPEG or GIF files) cannot be used.
Guidelines for producing publication-quality artwork is available via the OVS/Editorial Manager homepage by clicking “5 Steps to Creating Digital Artwork (PDF)”.
Upload figures consecutively, and number them in the order in which they are discussed in the text. All electronic art that cannot be successfully uploaded must be submitted via overnight courier to the Editorial Office on a CD-ROM, accompanied by high-resolution laser prints of each image.
Color figures: The journal accepts for publication color figures that will enhance an article. Color images must be created/scanned and saved and submitted as CMYK files. Authors who submit color figures are expected to pay the cost for the print publication. If they decide not to pay for color reproduction, the figures will be converted to black and white at no charge. The color versions of their figures will appear, at no charge, in the online version of the journal at www.opvissci.com.
Style: Pattern manuscript style after the American Medical Association Manual of Style (9th edition). Stedman’s Medical Dictionary (27th edition) and Merriam Webster’s Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. The name should not be abbreviated. Use code numbers only when a generic name is not yet available. Copyright or trade names of drugs should be capitalized and placed in parentheses after the name of the drug. Names and locations (city and state in USA; city and country outside USA) of manufacturers of drugs, supplies, or equipment cited in a manuscript are required to comply with trademark law and should be provided in parentheses. Units of measure should be expressed in the metric system (with the possible exception of visual acuity), and temperatures should be expressed in degrees Celsius. Conventional units should be written as SI units as appropriate.
AFTER ACCEPTANCE
Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Proofs must be checked carefully and corrections emailed, faxed and/or electronically returned to the publisher within 48 hours of receipt.
It is the author’s responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors’ meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries.
PDF files of the typeset pages and support documents (eg, reprint order form) will be made available on a secure website. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing or electronic submission of the corrected page proofs to the publisher.
Reprints: Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be emailed or faxed to the publisher with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106 with any questions.
Publisher’s contact: Email or fax corrected page proofs, reprint order form, and any other related materials to Journal Production Editor, Optometry and Vision Science, 215-521-8483 or 215-521-8485.
